{"gene":"STARD3","run_date":"2026-06-10T07:46:42","timeline":{"discoveries":[{"year":1997,"finding":"The C-terminal START/StAR Homology Domain (SHD) of MLN64/STARD3 is necessary and sufficient for steroidogenic activity; deletion of this domain abolishes steroidogenesis, while removal of N-terminal sequences increases it. MLN64 stimulates pregnenolone secretion ~2-fold in COS-1 cells co-transfected with the cholesterol side-chain cleavage enzyme system.","method":"COS-1 cell transfection with wild-type and deletion/truncation mutants of MLN64 co-expressed with cholesterol side-chain cleavage enzyme system; pregnenolone secretion assay","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Strong — functional reconstitution assay with systematic mutagenesis/deletion constructs, replicated across multiple construct variants in one rigorous study","pmids":["9237999"],"is_preprint":false},{"year":1997,"finding":"The N-terminal transmembrane domain of MLN64/STARD3 is responsible for its specific cytoplasmic (perinuclear, bundle-like) localization; deletion of this domain results in uniform cytoplasmic distribution.","method":"Deletion mutagenesis with subcellular localization by immunofluorescence microscopy in transfected cells","journal":"International journal of cancer","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — deletion mutant with direct localization readout, single lab but two orthogonal observations (IHC and mutagenesis)","pmids":["9139840"],"is_preprint":false},{"year":2000,"finding":"MLN64/STARD3 localizes exclusively to the limiting membrane of late endosomes via its N-terminal domain, with the START domain projecting into the cytoplasm. A dileucine motif (Leu66-Leu67) and tyrosine residue (Tyr89) in the N-terminal domain are critical for late endosomal targeting or proper folding. MLN64 colocalizes with NPC1 and cholesterol on late endosomes but does not complement NPC2 disease.","method":"Immunocytofluorescence, electron microscopy, antibody microinjection/endocytosis, deletion and point mutagenesis of targeting signals, complementation assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (EM, IF, functional complementation, mutagenesis) in one study, rigorous controls","pmids":["11053434"],"is_preprint":false},{"year":2000,"finding":"The truncated N-218 MLN64 protein (lacking 218 N-terminal residues) has StAR-like steroidogenic activity in vitro, stimulating cholesterol transfer from outer to inner mitochondrial membrane. It adopts a molten-globule-like conformation with pH-dependent structural transitions, and its C-terminus is proteolytically accessible while residues 244–414 are resistant, similar to StAR. MLN64 is proteolytically cleaved in the placenta to a size matching N-218 MLN64.","method":"Bacterially expressed N-218 MLN64 tested in isolated mitochondria steroidogenesis assay; CD spectroscopy; limited proteolysis + mass spectrometry; Western blot of human placenta","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — reconstitution in vitro, biophysical characterization (CD), proteolysis mapping, and Western blot validation, multiple orthogonal methods in one study","pmids":["10995240"],"is_preprint":false},{"year":2000,"finding":"Both StAR and N-218 MLN64 act on the outer mitochondrial membrane as molten globules to promote cholesterol transfer; this activity does not require entry into the intramembranous space. Bacterially expressed N-218 MLN64 is active with isolated mitochondria, confirming proper folding.","method":"Isolated mitochondria steroidogenesis assay; far-UV CD spectroscopy; urea denaturation; fluorescence spectroscopy; partial proteolysis + mass spectrometry; Western blot","journal":"Endocrine research","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution and biophysical analysis; single study but multiple orthogonal methods","pmids":["11196440"],"is_preprint":false},{"year":2002,"finding":"The N-terminal transmembrane domains of MLN64 mediate its endocytosis from the plasma membrane to late endocytic compartments. The START domain transfers free cholesterol from donor to acceptor mitochondrial membranes and enhances steroidogenesis by placental mitochondria. A dominant-negative ΔStart-MLN64 mutant causes free cholesterol accumulation in lysosomes, inhibits late endocytic dynamics, and suppresses steroidogenesis, demonstrating the START domain's role in lysosomal cholesterol mobilization.","method":"GFP-tagged MLN64 trafficking analysis; START domain cholesterol transfer assay with isolated mitochondria; ΔStart dominant-negative overexpression; steroidogenesis assay in COS cells","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (live cell imaging, in vitro transfer assay, dominant-negative genetics, steroidogenesis), replicated in multiple cell types","pmids":["12070139"],"is_preprint":false},{"year":2002,"finding":"MENTHO, an MLN64 N-terminal domain (MENTAL domain) homologue, interacts with MLN64 via the MENTAL domain; both proteins homo- and hetero-dimerize through this domain. The MENTAL domain targets proteins to late endosomal membranes and binds cholesterol in vivo. MENTHO overexpression alters the endocytic compartment, causing accumulation of enlarged endosomes.","method":"cDNA cloning; overexpression and subcellular localization; cholesterol-binding assays; interaction studies; endosome morphology analysis","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — biochemical interaction and localization data plus functional overexpression phenotype; single study","pmids":["12393907"],"is_preprint":false},{"year":2004,"finding":"N-218 MLN64 stimulates cholesterol transfer between artificial phospholipid vesicles (initial rate 6.5 mol/min·mol) and to the inner mitochondrial membrane of human placental mitochondria (~6-fold stimulation of pregnenolone synthesis), comparable to N-62 StAR. Both proteins undergo pH-dependent molten globule transitions. MLN64 levels in JEG-3 placental cells are unresponsive to cAMP stimulation.","method":"In vitro cholesterol transfer assay with phospholipid vesicles; isolated placental mitochondria steroidogenesis assay; urea denaturation; CD spectroscopy; 8-Br-cAMP stimulation of JEG-3 cells","journal":"Endocrinology","confidence":"High","confidence_rationale":"Tier 1 / Strong — reconstituted in vitro lipid transfer assay plus mitochondrial function assay, multiple orthogonal methods in one rigorous study","pmids":["14715710"],"is_preprint":false},{"year":2004,"finding":"Targeted mutation of the MLN64 START domain in mice causes only modest alterations in sterol metabolism; mice are viable, fertile, and neurologically intact with no major lipid abnormalities. However, embryonic fibroblasts and granulosa cells from mutant mice show reduced conversion of endogenous cholesterol to steroid hormones, indicating a cell-type-specific role of the START domain in sterol trafficking for steroidogenesis.","method":"Targeted mouse gene knockout/mutation; plasma lipid analysis; liver lipid distribution; steroidogenesis assay in primary granulosa cells and transfected embryonic fibroblasts","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo genetic model with multiple cellular and biochemical readouts, multiple orthogonal methods","pmids":["14963026"],"is_preprint":false},{"year":2004,"finding":"Overexpression of full-length MLN64 in hepatocytes blunts StAR-, SCP-2-, and CYP7A1-upregulated bile acid synthesis by ~45–48%, suggesting that full-length MLN64 does not deliver cholesterol to mitochondria or ER for CYP27A1/CYP7A1 and may act as a dominant negative in this context.","method":"Adenovirus-mediated overexpression of MLN64, StAR, SCP-2, CYP7A1 in primary rat hepatocytes; bile acid synthesis measurement","journal":"Journal of lipid research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional cell-based assay with multiple co-expression conditions; single lab","pmids":["15342684"],"is_preprint":false},{"year":2005,"finding":"MLN64 depletion causes dispersion of late endocytic organelles to the cell periphery, decreased actin and Arp2/3 (p34-Arc) association with endosomes, impaired fusion of late endocytic organelles, and delayed cargo degradation. MLN64 overexpression increases actin/p34-Arc-positive patches on late endosomes and enhances fusion in an actin-dependent manner. Cholesterol-binding-deficient MLN64 mutants cannot rescue the dispersion phenotype, linking MLN64-mediated sterol transfer to actin-dependent late endosome dynamics.","method":"siRNA knockdown; overexpression; live-cell imaging; immunofluorescence for actin and p34-Arc; cargo degradation assay; rescue experiments with cholesterol-binding mutants","journal":"Molecular biology of the cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — KD and OE with multiple readouts, mechanistic rescue with point mutants, multiple orthogonal methods in one study","pmids":["15930133"],"is_preprint":false},{"year":2006,"finding":"The MENTAL domain mediates MLN64 homo- and hetero-interactions with MENTHO, targets both proteins to late endosomal membranes, and binds cholesterol in vivo; the START domain then shuttles cholesterol to cytoplasmic acceptors.","method":"Biochemical characterization; cholesterol-binding assays; subcellular fractionation/localization (review/summary of prior experiments)","journal":"Biochemical Society transactions","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — review summarizing multiple prior experiments from the same lab; consolidates findings but not new primary data","pmids":["16709157"],"is_preprint":false},{"year":2008,"finding":"STARD3-START domain and STARD1-START domain differ in their cholesterol-binding modes: cholesterol stabilizes STARD3-START against trypsin degradation (not STARD1-START); photoaffinity labeling with [3H]azocholestanol labels a specific 6.2 kDa fragment in STARD1-START at the hydrophobic cavity wall, whereas label distributes more equally across STARD3-START polypeptides, indicating differential cholesterol-binding mechanisms.","method":"Trypsin protection assay; photoaffinity labeling with [3H]azocholestanol; limited proteolysis","journal":"The FEBS journal","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — direct in vitro biochemical assays comparing the two START domains, single lab with multiple orthogonal methods","pmids":["18331352"],"is_preprint":false},{"year":2009,"finding":"MLN64 mediates cholesterol transport from late endosomes to mitochondria independently of NPC1. siRNA knockdown of MLN64 in NPC1-deficient CHO cells decreases cholesterol transport to the inner mitochondrial membrane (measured by pregnenolone production) and reduces mitochondrial cholesterol content, establishing MLN64 as required for an NPC1-independent endosome-to-mitochondria cholesterol transport pathway.","method":"RNA interference (siRNA) in NPC1-deficient CHO cells stably expressing CYP11A1 complex; pregnenolone production assay; mitochondrial cholesterol content measurement","journal":"Journal of lipid research","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean RNAi with defined functional readout (steroidogenesis), mitochondrial cholesterol measurement, genetic epistasis with NPC1 loss","pmids":["19965586"],"is_preprint":false},{"year":2011,"finding":"STARD3/MLN64 selectively binds lutein with high affinity (Kd = 0.45 µM) in the primate retina. Recombinant STARD3 binds lutein (but not zeaxanthin) as assessed by surface plasmon resonance, identifying STARD3 as the macular lutein-binding protein.","method":"Surface plasmon resonance (SPR) binding assay with recombinant STARD3; Western blotting; immunohistochemistry in monkey retina","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — direct binding quantified by SPR with recombinant protein, validated by immunolocalization, single lab","pmids":["21322544"],"is_preprint":false},{"year":2012,"finding":"MLN64 interacts with 14-3-3 proteins at a non-canonical binding site; blocking this interaction (by 14-3-3 antagonist or MLN64 mutagenesis) delays trafficking of MLN64 to the late endosome and disperses endocytic vesicles to the cell periphery, identifying 14-3-3 as a regulator of MLN64 endosomal trafficking.","method":"Affinity chromatography and mass spectrometry to identify interacting partners; co-immunoprecipitation in vitro and in vivo; MLN64 mutagenesis; 14-3-3 antagonist treatment; subcellular localization analysis","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — MS-identified interaction confirmed by Co-IP and functional mutagenesis, single lab","pmids":["22514632"],"is_preprint":false},{"year":2012,"finding":"LeTx/caspase-1 signaling triggers mitochondrial translocation of MLN64, causing mitochondrial cholesterol enrichment, membrane hyperpolarization, reactive oxygen species generation, and glutathione depletion. Downregulation of MLN64 in toxin-induced-resistant (TIR) cells (mediated by DNMT1-dependent DNA methylation) prevents these mitochondrial events without blocking caspase-1 activation.","method":"Subcellular fractionation; cholesterol measurement; mitochondrial membrane potential assay; ROS measurement; siRNA knockdown; DNA methylation analysis; primary macrophage experiments","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional knockdown with multiple organelle-level readouts, single lab, multiple methods","pmids":["23028046"],"is_preprint":false},{"year":2013,"finding":"MLN64/STARD3 and ORP1L define two distinct subpopulations of late endosomes: MLN64-positive LEs contain ABCA3 and receive endocytosed cargo first, cycling between LE and plasma membrane; ORP1L-positive LEs contain NPC1 and are reached later. MLN64/ABCA3 compartments frequently contact ORP1L/NPC1-containing LEs.","method":"Fluorescence microscopy; co-localization analysis; live-cell imaging of endocytic cargo trafficking","journal":"Journal of lipid research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — live imaging with defined cargo tracking, single lab, two orthogonal markers","pmids":["23709693"],"is_preprint":false},{"year":2014,"finding":"Mitochondrial metalloproteases cleave STARD3 into a 28-kDa fragment that stimulates progesterone synthesis in isolated human syncytiotrophoblast mitochondria. Metalloprotease inhibitor 1,10-phenanthroline blocks both STARD3 cleavage and steroidogenesis; the 28-kDa fragment stimulates steroidogenesis comparably to truncated STARD3, suggesting proteolytic activation of STARD3 is required for placental cholesterol transport.","method":"Isolated syncytiotrophoblast mitochondria; progesterone measurement; Western blot with anti-STARD3; protease inhibitor experiments; 22R-hydroxycholesterol bypass control","journal":"Biochimica et biophysica acta","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional reconstitution in isolated organelles with inhibitor validation, single lab","pmids":["25459514"],"is_preprint":false},{"year":2016,"finding":"Crystal structure of the lutein-binding domain of human STARD3 refined to 1.74 Å resolution reveals a helix-grip fold around a solvent-filled cavity; rigid-body docking models of lutein indicate one ionone ring must protrude outside the cavity, and steric complementarity involving the ε-ionone ring of lutein may discriminate it from zeaxanthin/meso-zeaxanthin.","method":"X-ray crystallography (1.74 Å resolution); rigid-body docking of lutein","journal":"Acta crystallographica. Section F, Structural biology communications","confidence":"High","confidence_rationale":"Tier 1 / Moderate — crystal structure with docking validation; single lab but direct structural determination","pmids":["27487925"],"is_preprint":false},{"year":2016,"finding":"STARD3 and its paralogue STARD3NL tether late endosomes to the ER by directly interacting with ER-resident VAP proteins (VAP-A and VAP-B). Both proteins are anchored on late endosomal limiting membranes and the STARD3–VAP interaction scaffolds ER–endosome contact sites affecting endosome dynamics and cholesterol transport.","method":"Co-immunoprecipitation; subcellular fractionation; fluorescence co-localization; functional analysis of ER-endosome contacts (review citing own original data)","journal":"Biochemical Society transactions","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — review summarizing interaction data; original mechanistic findings from cited primary work (e.g., PMID 28377464)","pmids":["27068960"],"is_preprint":false},{"year":2017,"finding":"STARD3 mediates ER-to-endosome cholesterol transport at membrane contact sites. STARD3 induces cholesterol accumulation in endosomes at the expense of the plasma membrane. This transport requires both STARD3's lipid transfer (START domain) activity and its ability to form ER-endosome contacts via interaction with VAP (VAMP-associated protein). In vitro reconstitution demonstrated that STARD3 and VAP assemble into a machine enabling highly efficient cholesterol transport within membrane contacts.","method":"In situ cholesterol labeling and quantification; in vitro cholesterol transport reconstitution assay; STARD3 mutants deficient in lipid transfer or VAP interaction; cholesterol distribution analysis by filipin staining","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1 / Strong — reconstitution assay, mutagenesis separating two required functions, quantitative in-cell cholesterol measurement, multiple orthogonal methods in one study","pmids":["28377464"],"is_preprint":false},{"year":2017,"finding":"MLN64 overexpression increases mitochondrial cholesterol content and causes mitochondrial dysfunction including decreased GSH, decreased ATPase activity, decreased mitochondrial membrane potential, mitochondrial fragmentation, and increased mitochondrial superoxide. Reduction of MLN64 expression in NPC1-deficient cells restores mitochondrial membrane potential and reduces superoxide levels, confirming MLN64's role in delivering cholesterol to mitochondria.","method":"Adenovirus-mediated MLN64 overexpression in mouse liver and hepatocytes; siRNA knockdown in NPC1-deficient cells; mitochondrial membrane potential (JC-1), ROS, GSH, ATPase assays; electron microscopy","journal":"Redox biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — overexpression and knockdown with multiple mitochondrial functional readouts; single lab","pmids":["28282615"],"is_preprint":false},{"year":2019,"finding":"In NPC1 mutant cells lacking AnxA6, Rab7 activation promotes ER-endosome membrane contact site formation in a STARD3-dependent manner, enabling late endosome-to-ER cholesterol transfer. Electron microscopy confirmed increased LE-ER MCS in AnxA6-deficient NPC1 cells, and genetic depletion of STARD3 was required for Rab7-mediated rescue of cholesterol export.","method":"siRNA knockdown of STARD3 and AnxA6; electron microscopy of MCS; cholesterol distribution (filipin); lipid droplet staining; genetic epistasis between AnxA6, TBC1D15/Rab7, and STARD3","journal":"Cellular and molecular life sciences : CMLS","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — epistasis with multiple knockdowns and EM validation; single lab, multiple orthogonal methods","pmids":["31664461"],"is_preprint":false},{"year":2022,"finding":"External cholesterol alters airway epithelial inflammatory sensitivity through a STARD3-MFN2 signaling pathway, causing cholesterol redistribution, altered mitochondrial dynamics, and increased IL production. STARD3 regulation of MFN2 links cholesterol transport to mitochondrial function in bronchial epithelial cells.","method":"siRNA knockdown; Western blot; RT-qPCR; mitotracker; Seahorse metabolic assay; lipidomics; electron microscopy","journal":"Clinical and translational medicine","confidence":"Low","confidence_rationale":"Tier 3 / Weak — mechanistic pathway proposed from KD phenotype; single lab, indirect evidence for STARD3-MFN2 interaction","pmids":["35678098"],"is_preprint":false},{"year":2023,"finding":"STARD3 interacts directly with HSP90 and induces phosphorylated SRC signaling, protecting HER2 from lysosomal degradation. STARD3 overexpression increases HER2 protein levels; STARD3 loss leads to HER2 degradation via lysosomes. STARD3 also promotes cell cycle progression by inducing cyclin D1 and reducing p27.","method":"Co-immunoprecipitation (STARD3-HSP90); Western blot for HER2, phospho-SRC, cyclin D1, p27; siRNA knockdown; overexpression; lysosomal inhibitor experiments","journal":"American journal of cancer research","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — Co-IP plus functional KD/OE with multiple molecular readouts; single lab","pmids":["38058811"],"is_preprint":false},{"year":2023,"finding":"STARD3 binds all three MSRB isoforms (methionine sulfoxide reductase B) in addition to MSRA; Met307 and Met427 of STARD3 are oxidized by cholesterol-6α-hydroperoxide and cholesterol-7α-hydroperoxide. MSRs reduce these oxidized methionines back to methionine, restoring STARD3 cholesterol-binding activity. This cyclic oxidation-reduction constitutes an efficient mechanism to detoxify cholesterol hydroperoxides during cholesterol transport.","method":"Biochemical binding assays; treatment with pure cholesterol hydroperoxide isomers; mass spectrometry of oxidized methionines; MSR-mediated reduction assays; cholesterol-binding activity measurement before/after oxidation","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — direct in vitro biochemical demonstration of oxidation sites by MS, functional restoration of activity, single lab with multiple orthogonal methods","pmids":["37507014"],"is_preprint":false},{"year":2023,"finding":"MLN64 is required for the formation of late endosome–mitochondria membrane contact sites in placental cells. Immuno-electron tomography revealed filamentous tethers connecting late endosomes and mitochondria at <20 nm distance; STARD3 knockdown increased this distance to <150 nm and disrupted tether formation. Perturbation of cholesterol egress from endosomes produced an even longer inter-organelle distance.","method":"Immuno-electron microscopy; immuno-electron tomography; STARD3 siRNA knockdown; U18666A treatment; distance measurement of contact sites","journal":"Experimental cell research","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct ultrastructural evidence by electron tomography combined with genetic knockdown and pharmacological perturbation, multiple orthogonal approaches","pmids":["37245582"],"is_preprint":false},{"year":2024,"finding":"LIMP-2 physically interacts with STARD3 and ER-resident VAPB at ER-lysosome contact sites, and STARD3 is required for the LIMP-2–VAPB interaction. Co-immunoprecipitation and imaging confirmed colocalization and physical interaction, suggesting STARD3 scaffolds a LIMP-2–STARD3–VAPB complex at ER-lysosome MCS to facilitate cholesterol transfer.","method":"Proximity-based interaction screen (BioID); co-immunoprecipitation; fluorescence colocalization; STARD3 depletion to test LIMP-2/VAPB interaction dependency","journal":"Journal of cell science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — proximity screen confirmed by Co-IP and imaging with epistasis test; single lab","pmids":["39370902"],"is_preprint":false},{"year":2024,"finding":"Upregulation of STARD3 under diabetic/hyperglycemic conditions increases cholesterol transport from late endosomes/lysosomes to mitochondria in podocytes, causing mitochondrial cholesterol accumulation and cell injury. Downregulating STARD3 expression attenuates mitochondrial cholesterol accumulation and improves mitochondrial homeostasis.","method":"In vivo and in vitro diabetic models; filipin staining for cholesterol subcellular localization; JC-1 for mitochondrial membrane potential; ROS assay; Western blot; siRNA knockdown","journal":"Life sciences","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — KD with defined cholesterol redistribution and mitochondrial functional readouts in disease context; single lab","pmids":["38754814"],"is_preprint":false},{"year":2026,"finding":"GSK3α and GSK3β phosphorylate serine 209 within the Phospho-FFAT motif of STARD3; this phosphorylation is both necessary and sufficient to activate STARD3's tethering activity, promoting ER–late endosome/lysosome contacts. When ER–LE/Lys tethering is prevented (loss of GSK3-mediated phosphorylation), STARD3 triggers LE/Lys homotypic interactions, revealing a second function in endosome biology.","method":"Kinase identification by cell-based and biochemical assays; phospho-site mutagenesis (S209); GSK3 inhibition; live-cell imaging of ER-endosome MCS; endosome positioning analysis","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — kinase-site mutagenesis demonstrating necessity and sufficiency, pharmacological GSK3 inhibition, live-cell imaging, and functional endosome phenotype; multiple orthogonal methods","pmids":["41741634"],"is_preprint":false}],"current_model":"STARD3/MLN64 is a late endosomal transmembrane protein whose N-terminal MENTAL domain anchors it to the limiting membrane of late endosomes and mediates homo/heterodimerization, while its cytoplasmic C-terminal START domain binds and transfers cholesterol (one molecule at a time, in a molten-globule-dependent manner) to mitochondria and, at ER–endosome membrane contact sites, to the ER; these contacts are scaffolded by STARD3's Phospho-FFAT motif interacting with ER-resident VAP proteins, a tethering activity switched on by GSK3α/β-mediated phosphorylation of Ser209, and STARD3 additionally regulates actin-dependent late endosome dynamics, forms late endosome–mitochondria contact sites, serves as a retinal lutein-binding protein, and participates in a methionine-oxidation cycle with MSR enzymes to detoxify cholesterol hydroperoxides during transport."},"narrative":{"mechanistic_narrative":"STARD3 (MLN64) is a late endosomal transmembrane sterol-transfer protein that mobilizes cholesterol from late endosomes/lysosomes to mitochondria and the ER, coupling endosomal lipid handling to steroidogenesis, organelle dynamics, and membrane contact site formation [PMID:12070139, PMID:19965586, PMID:28377464]. Its modular architecture separates targeting from transfer: an N-terminal MENTAL/transmembrane domain anchors the protein to the limiting membrane of late endosomes, mediates homo- and hetero-dimerization (including with MENTHO), and binds cholesterol, while the C-terminal START domain projects into the cytoplasm and shuttles single cholesterol molecules to acceptor membranes [PMID:11053434, PMID:12393907, PMID:16709157]. The START domain is necessary and sufficient for StAR-like steroidogenic activity, stimulating cholesterol transfer to the inner mitochondrial membrane and between phospholipid vesicles as a pH-dependent molten globule, and is proteolytically liberated as an N-218/28-kDa fragment that drives placental steroid synthesis [PMID:9237999, PMID:10995240, PMID:14715710, PMID:25459514]. This NPC1-independent endosome-to-mitochondria cholesterol route, and the resulting mitochondrial cholesterol loading, governs steroidogenesis but also drives mitochondrial dysfunction—membrane hyperpolarization, ROS, and GSH depletion—when overactive [PMID:19965586, PMID:28282615, PMID:23028046]. STARD3 builds the membrane contact sites underlying this transport: it tethers late endosomes to the ER by binding ER-resident VAP-A/VAP-B through a Phospho-FFAT motif, an interaction switched on by GSK3α/β phosphorylation of Ser209, and reconstitution shows STARD3–VAP assemble an efficient ER-to-endosome cholesterol-transport machine [PMID:27068960, PMID:28377464, PMID:41741634]. STARD3 likewise organizes late endosome–mitochondria contacts and actin/Arp2/3-dependent late endosome dynamics, both dependent on its cholesterol-binding activity [PMID:15930133, PMID:37245582]. Beyond cholesterol, STARD3 is the retinal lutein-binding protein, selectively binding lutein over zeaxanthin via its helix-grip START fold [PMID:21322544, PMID:27487925], and undergoes a protective methionine-oxidation/MSR-reduction cycle that detoxifies cholesterol hydroperoxides during transport [PMID:37507014].","teleology":[{"year":1997,"claim":"Established that STARD3 has a modular two-domain organization, defining the C-terminal START domain as the steroidogenic effector and the N-terminal region as the localization determinant.","evidence":"Deletion/truncation mutants co-expressed with cholesterol side-chain cleavage system and localized by immunofluorescence","pmids":["9237999","9139840"],"confidence":"High","gaps":["Did not identify the precise organelle of localization","Mechanism of cholesterol transfer not resolved"]},{"year":2000,"claim":"Pinpointed the late endosomal limiting membrane as STARD3's residence and showed the isolated START domain acts as a molten globule transferring cholesterol to mitochondria, resolving how the domains divide labor.","evidence":"EM/IF localization with targeting-motif mutagenesis; bacterially expressed N-218 fragment in isolated mitochondria steroidogenesis and CD spectroscopy","pmids":["11053434","10995240","11196440"],"confidence":"High","gaps":["Did not establish physiological cleavage in non-placental tissues","Acceptor specificity beyond mitochondria unaddressed"]},{"year":2002,"claim":"Defined the MENTAL domain as the dimerization/cholesterol-binding/endosome-targeting module and showed the START domain mobilizes lysosomal cholesterol, linking sterol transfer to late endocytic function.","evidence":"GFP trafficking, in vitro mitochondrial transfer assay, ΔStart dominant-negative overexpression, and MENTHO interaction/cholesterol-binding assays","pmids":["12070139","12393907"],"confidence":"High","gaps":["Native heterodimer stoichiometry unknown","How MENTAL-bound cholesterol is handed to START not defined"]},{"year":2004,"claim":"Quantified START-domain cholesterol transfer kinetics and tested physiological requirement in vivo, revealing only cell-type-specific steroidogenic dependence rather than global sterol disruption.","evidence":"In vitro vesicle/mitochondria transfer assays; targeted START-domain mouse mutant with lipid and steroidogenesis phenotyping; hepatocyte overexpression","pmids":["14715710","14963026","15342684"],"confidence":"High","gaps":["Redundancy with other sterol transporters not resolved","Full knockout not characterized in this corpus"]},{"year":2005,"claim":"Connected STARD3 sterol transfer to actin-dependent late endosome positioning and fusion, showing the cholesterol-binding function controls organelle dynamics.","evidence":"siRNA and overexpression with live imaging, actin/p34-Arc staining, and rescue with cholesterol-binding-deficient mutants","pmids":["15930133"],"confidence":"High","gaps":["Direct link between sterol level and Arp2/3 recruitment not mechanistically defined","Single lab"]},{"year":2008,"claim":"Demonstrated that the STARD3 START domain binds cholesterol by a mechanism distinct from STARD1, refining the structural basis of sterol recognition.","evidence":"Trypsin protection and photoaffinity labeling comparing STARD3-START and STARD1-START","pmids":["18331352"],"confidence":"Medium","gaps":["High-resolution cholesterol-bound structure not determined here","Functional consequence of differential binding unclear"]},{"year":2009,"claim":"Established STARD3 as required for an NPC1-independent endosome-to-mitochondria cholesterol route, placing it in a parallel pathway to canonical lysosomal cholesterol egress.","evidence":"siRNA in NPC1-deficient CHO cells with pregnenolone and mitochondrial cholesterol measurement","pmids":["19965586"],"confidence":"High","gaps":["Direct LE-mitochondria transfer mechanism not visualized here","Contribution relative to NPC1 pathway in vivo unquantified"]},{"year":2011,"claim":"Identified STARD3 as the macular lutein-binding protein, extending its ligand repertoire beyond cholesterol.","evidence":"Surface plasmon resonance with recombinant STARD3 and retinal immunohistochemistry","pmids":["21322544"],"confidence":"High","gaps":["Physiological role of lutein binding in retina not established","Whether lutein and cholesterol binding compete unknown"]},{"year":2012,"claim":"Identified regulatory and stress-responsive control of STARD3 trafficking and mitochondrial translocation, showing its localization is actively governed.","evidence":"14-3-3 interaction by MS/Co-IP and mutagenesis; LeTx/caspase-1-induced mitochondrial translocation with organelle readouts","pmids":["22514632","23028046"],"confidence":"Medium","gaps":["14-3-3 binding site not structurally defined","Signaling upstream of mitochondrial translocation incompletely mapped"]},{"year":2013,"claim":"Resolved STARD3 into a distinct late endosome subpopulation that contacts NPC1/ORP1L compartments, organizing endosomal cholesterol handling spatially.","evidence":"Live-cell imaging and colocalization tracking of MLN64/ABCA3 versus ORP1L/NPC1 endosomes","pmids":["23709693"],"confidence":"Medium","gaps":["Molecular basis of subpopulation segregation unknown","Functional cargo exchange between compartments not measured"]},{"year":2014,"claim":"Showed mitochondrial metalloprotease cleavage generates an active STARD3 fragment required for placental steroidogenesis, defining proteolytic activation.","evidence":"Isolated syncytiotrophoblast mitochondria, protease inhibitor, and progesterone assays","pmids":["25459514"],"confidence":"Medium","gaps":["Identity of the responsible metalloprotease unresolved","In vivo relevance of cleavage outside placenta unclear"]},{"year":2016,"claim":"Determined the helix-grip structure of the START fold and demonstrated direct VAP-dependent ER-endosome tethering, establishing the structural and contact-site machinery.","evidence":"1.74 Å crystal structure with lutein docking; Co-IP and colocalization of STARD3/STARD3NL with VAP-A/VAP-B","pmids":["27487925","27068960"],"confidence":"High","gaps":["Cholesterol-bound structure not solved","FFAT motif and phospho-regulation not yet defined here"]},{"year":2017,"claim":"Reconstituted STARD3–VAP as an ER-to-endosome cholesterol-transport machine requiring both lipid transfer and tethering, and linked excess transport to mitochondrial dysfunction.","evidence":"In vitro transport reconstitution with function-separating mutants and in-cell filipin cholesterol mapping; overexpression/knockdown mitochondrial functional assays","pmids":["28377464","28282615"],"confidence":"High","gaps":["Directionality and regulation of transport in vivo not fully resolved","Coupling between contact formation and transfer rate unquantified"]},{"year":2019,"claim":"Placed STARD3-dependent ER-endosome contacts within a Rab7/AnxA6-controlled rescue pathway for cholesterol export in NPC1 disease, integrating it with contact-site regulators.","evidence":"siRNA epistasis among STARD3, AnxA6, and TBC1D15/Rab7 with EM of contact sites and filipin","pmids":["31664461"],"confidence":"Medium","gaps":["Mechanism by which Rab7 activation promotes STARD3 contacts unclear","Therapeutic relevance untested"]},{"year":2023,"claim":"Expanded STARD3's interactome and protective biochemistry, defining LE-mitochondria contacts, a methionine-oxidation/MSR detox cycle, and an HSP90/HER2 stabilizing role.","evidence":"Immuno-electron tomography with STARD3 knockdown; MS mapping of oxidized Met307/Met427 with MSR reduction assays; Co-IP and KD/OE of HER2/phospho-SRC pathway","pmids":["37245582","37507014","38058811"],"confidence":"High","gaps":["How LE-mitochondria tethers form molecularly not fully defined","STARD3-HSP90-HER2 mechanism is single-lab and indirect"]},{"year":2024,"claim":"Extended STARD3's contact-site scaffolding and disease relevance, showing it bridges LIMP-2–VAPB at ER-lysosome contacts and drives mitochondrial cholesterol injury in diabetic podocytes.","evidence":"BioID/Co-IP with STARD3-depletion epistasis; diabetic in vivo/in vitro models with filipin and mitochondrial readouts","pmids":["39370902","38754814"],"confidence":"Medium","gaps":["Stoichiometry of LIMP-2–STARD3–VAPB complex unknown","Causality in disease versus correlation not fully separated"]},{"year":2026,"claim":"Identified GSK3α/β phosphorylation of Ser209 as the switch activating STARD3 tethering, and uncovered a second STARD3 function promoting homotypic endosome interactions when tethering is off.","evidence":"Kinase identification, S209 phospho-mutagenesis, GSK3 inhibition, and live-cell imaging of ER-endosome contacts and endosome positioning","pmids":["41741634"],"confidence":"High","gaps":["Upstream signals controlling GSK3 toward STARD3 unknown","Physiological trigger toggling between tethering and homotypic function undefined"]},{"year":null,"claim":"How STARD3's multiple roles—cholesterol transfer, lutein binding, contact-site tethering, and oxidative detoxification—are coordinated and prioritized within a single cell remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No integrated model of how ligand selection (cholesterol vs lutein) is regulated","Tissue-specific functional hierarchy not established","In vivo loss-of-function consequences beyond conditional models incompletely defined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0008289","term_label":"lipid binding","supporting_discovery_ids":[3,5,6,7,14,21,26]},{"term_id":"GO:0140104","term_label":"molecular carrier activity","supporting_discovery_ids":[5,13,21]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[20,21,28]}],"localization":[{"term_id":"GO:0005768","term_label":"endosome","supporting_discovery_ids":[2,5,6,17]},{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[20,21,28]},{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[13,16,22,27]},{"term_id":"GO:0005764","term_label":"lysosome","supporting_discovery_ids":[5,28]}],"pathway":[{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[0,5,13,21]},{"term_id":"R-HSA-5653656","term_label":"Vesicle-mediated transport","supporting_discovery_ids":[20,21,27]}],"complexes":["STARD3-VAP ER-endosome contact tether","LIMP-2-STARD3-VAPB ER-lysosome contact complex","MLN64-MENTHO heterodimer"],"partners":["VAPA","VAPB","STARD3NL","MENTHO","HSP90","LIMP-2","MFN2","MSRA"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q14849","full_name":"StAR-related lipid transfer protein 3","aliases":["Metastatic lymph node gene 64 protein","MLN 64","Protein CAB1","START domain-containing protein 3","StARD3"],"length_aa":445,"mass_kda":50.5,"function":"Sterol-binding protein that mediates cholesterol transport from the endoplasmic reticulum to endosomes (PubMed:11053434, PubMed:15930133, PubMed:22514632, PubMed:28377464, PubMed:33124732). The sterol transport mechanism is triggered by phosphorylation of FFAT motif that leads to membrane tethering between the endoplasmic reticulum and late endosomes via interaction with VAPA and VAPB (PubMed:24105263, PubMed:28377464, PubMed:33124732). Acts as a lipid transfer protein that redirects sterol to the endosome at the expense of the cell membrane and favors membrane formation inside endosomes (PubMed:28377464). May also mediate cholesterol transport between other membranes, such as mitochondria membrane or cell membrane (PubMed:12070139, PubMed:19965586). However, such results need additional experimental evidences; probably mainly mediates cholesterol transport from the endoplasmic reticulum to endosomes (PubMed:28377464). Does not activate transcriptional cholesterol sensing (PubMed:28377464). Able to bind other lipids, such as lutein, a xanthophyll carotenoids that form the macular pigment of the retina (PubMed:21322544)","subcellular_location":"Late endosome membrane","url":"https://www.uniprot.org/uniprotkb/Q14849/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/STARD3","classification":"Not Classified","n_dependent_lines":55,"n_total_lines":1208,"dependency_fraction":0.04552980132450331},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"LAMP1","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/STARD3","total_profiled":1310},"omim":[{"mim_id":"611802","title":"MIGRATION AND INVASION ENHANCER 1; MIEN1","url":"https://www.omim.org/entry/611802"},{"mim_id":"611801","title":"POST-GPI ATTACHMENT TO PROTEINS 3; PGAP3","url":"https://www.omim.org/entry/611801"},{"mim_id":"611759","title":"STARD3 N-TERMINAL-LIKE; STARD3NL","url":"https://www.omim.org/entry/611759"},{"mim_id":"607049","title":"START DOMAIN-CONTAINING PROTEIN 4; STARD4","url":"https://www.omim.org/entry/607049"},{"mim_id":"607048","title":"START DOMAIN-CONTAINING PROTEIN 3; STARD3","url":"https://www.omim.org/entry/607048"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nucleoplasm","reliability":"Approved"},{"location":"Vesicles","reliability":"Approved"},{"location":"Endoplasmic reticulum","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/STARD3"},"hgnc":{"alias_symbol":["es64","MLN64"],"prev_symbol":[]},"alphafold":{"accession":"Q14849","domains":[{"cath_id":"-","chopping":"47-189","consensus_level":"high","plddt":85.4084,"start":47,"end":189},{"cath_id":"3.30.530.20","chopping":"259-442","consensus_level":"high","plddt":94.6351,"start":259,"end":442}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q14849","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q14849-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q14849-F1-predicted_aligned_error_v6.png","plddt_mean":81.38},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=STARD3","jax_strain_url":"https://www.jax.org/strain/search?query=STARD3"},"sequence":{"accession":"Q14849","fasta_url":"https://rest.uniprot.org/uniprotkb/Q14849.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q14849/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q14849"}},"corpus_meta":[{"pmid":"28377464","id":"PMC_28377464","title":"STARD3 mediates endoplasmic reticulum-to-endosome cholesterol transport at membrane contact sites.","date":"2017","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/28377464","citation_count":215,"is_preprint":false},{"pmid":"9237999","id":"PMC_9237999","title":"MLN64 contains a domain with homology to the steroidogenic acute regulatory protein (StAR) that stimulates steroidogenesis.","date":"1997","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/9237999","citation_count":215,"is_preprint":false},{"pmid":"19965586","id":"PMC_19965586","title":"MLN64 mediates egress of cholesterol from endosomes to mitochondria in the absence of functional Niemann-Pick Type C1 protein.","date":"2009","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/19965586","citation_count":156,"is_preprint":false},{"pmid":"11053434","id":"PMC_11053434","title":"The steroidogenic acute regulatory protein homolog MLN64, a late endosomal cholesterol-binding protein.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11053434","citation_count":141,"is_preprint":false},{"pmid":"21322544","id":"PMC_21322544","title":"Identification of StARD3 as a lutein-binding protein in the macula of the primate retina.","date":"2011","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21322544","citation_count":138,"is_preprint":false},{"pmid":"12070139","id":"PMC_12070139","title":"MLN64 mediates mobilization of lysosomal cholesterol to steroidogenic mitochondria.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12070139","citation_count":130,"is_preprint":false},{"pmid":"9139840","id":"PMC_9139840","title":"MLN64 exhibits homology with the steroidogenic acute regulatory protein (STAR) and is over-expressed in human breast carcinomas.","date":"1997","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/9139840","citation_count":121,"is_preprint":false},{"pmid":"16322295","id":"PMC_16322295","title":"Expression of HER2 and the coamplified genes GRB7 and MLN64 in human breast cancer: quantitative real-time reverse transcription-PCR as a diagnostic alternative to immunohistochemistry and fluorescence in situ hybridization.","date":"2005","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/16322295","citation_count":88,"is_preprint":false},{"pmid":"16990645","id":"PMC_16990645","title":"Modeling the structure of the StART domains of MLN64 and StAR proteins in complex with cholesterol.","date":"2006","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/16990645","citation_count":87,"is_preprint":false},{"pmid":"10995240","id":"PMC_10995240","title":"N-218 MLN64, a protein with StAR-like steroidogenic activity, is folded and cleaved similarly to StAR.","date":"2000","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10995240","citation_count":85,"is_preprint":false},{"pmid":"12021170","id":"PMC_12021170","title":"Characterization and expression of steroidogenic acute regulatory protein and MLN64 cDNAs in trout.","date":"2002","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/12021170","citation_count":85,"is_preprint":false},{"pmid":"23709693","id":"PMC_23709693","title":"Cholesterol-binding molecules MLN64 and ORP1L mark distinct late endosomes with transporters ABCA3 and NPC1.","date":"2013","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/23709693","citation_count":82,"is_preprint":false},{"pmid":"14963026","id":"PMC_14963026","title":"Targeted mutation of the MLN64 START domain causes only modest alterations in cellular sterol metabolism.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14963026","citation_count":71,"is_preprint":false},{"pmid":"12739007","id":"PMC_12739007","title":"MGC9753 gene, located within PPP1R1B-STARD3-ERBB2-GRB7 amplicon on human chromosome 17q12, encodes the seven-transmembrane receptor with extracellular six-cystein domain.","date":"2003","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/12739007","citation_count":71,"is_preprint":false},{"pmid":"28282615","id":"PMC_28282615","title":"MLN64 induces mitochondrial dysfunction associated with increased mitochondrial cholesterol content.","date":"2017","source":"Redox biology","url":"https://pubmed.ncbi.nlm.nih.gov/28282615","citation_count":67,"is_preprint":false},{"pmid":"15930133","id":"PMC_15930133","title":"MLN64 is involved in actin-mediated dynamics of late endocytic organelles.","date":"2005","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/15930133","citation_count":63,"is_preprint":false},{"pmid":"31664461","id":"PMC_31664461","title":"Annexin A6 modulates TBC1D15/Rab7/StARD3 axis to control endosomal cholesterol export in NPC1 cells.","date":"2019","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/31664461","citation_count":60,"is_preprint":false},{"pmid":"15342684","id":"PMC_15342684","title":"Effect of increasing the expression of cholesterol transporters (StAR, MLN64, and SCP-2) on bile acid synthesis.","date":"2004","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/15342684","citation_count":56,"is_preprint":false},{"pmid":"14715710","id":"PMC_14715710","title":"Molten globule structure and steroidogenic activity of N-218 MLN64 in human placental mitochondria.","date":"2004","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/14715710","citation_count":51,"is_preprint":false},{"pmid":"35678098","id":"PMC_35678098","title":"Regulatory roles of external cholesterol in human airway epithelial mitochondrial function through STARD3 signalling.","date":"2022","source":"Clinical and translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/35678098","citation_count":47,"is_preprint":false},{"pmid":"12393907","id":"PMC_12393907","title":"MENTHO, a MLN64 homologue devoid of the START domain.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12393907","citation_count":45,"is_preprint":false},{"pmid":"18331352","id":"PMC_18331352","title":"Cholesterol interaction with the related steroidogenic acute regulatory lipid-transfer (START) domains of StAR (STARD1) and MLN64 (STARD3).","date":"2008","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/18331352","citation_count":43,"is_preprint":false},{"pmid":"16709157","id":"PMC_16709157","title":"MLN64 and MENTHO, two mediators of endosomal cholesterol transport.","date":"2006","source":"Biochemical Society transactions","url":"https://pubmed.ncbi.nlm.nih.gov/16709157","citation_count":41,"is_preprint":false},{"pmid":"24276243","id":"PMC_24276243","title":"PPP1R1B-STARD3 chimeric fusion transcript in human gastric cancer promotes tumorigenesis through activation of PI3K/AKT signaling.","date":"2013","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/24276243","citation_count":39,"is_preprint":false},{"pmid":"20491656","id":"PMC_20491656","title":"Overexpression of STARD3 in human monocyte/macrophages induces an anti-atherogenic lipid phenotype.","date":"2010","source":"Clinical science (London, England : 1979)","url":"https://pubmed.ncbi.nlm.nih.gov/20491656","citation_count":36,"is_preprint":false},{"pmid":"27487925","id":"PMC_27487925","title":"Structure of the lutein-binding domain of human StARD3 at 1.74 Å resolution and model of a complex with lutein.","date":"2016","source":"Acta crystallographica. Section F, Structural biology communications","url":"https://pubmed.ncbi.nlm.nih.gov/27487925","citation_count":31,"is_preprint":false},{"pmid":"11196440","id":"PMC_11196440","title":"Evidence that StAR and MLN64 act on the outer mitochondrial membrane as molten globules.","date":"2000","source":"Endocrine research","url":"https://pubmed.ncbi.nlm.nih.gov/11196440","citation_count":30,"is_preprint":false},{"pmid":"12802284","id":"PMC_12802284","title":"Metastatic lymph node 64 (MLN64), a gene overexpressed in breast cancers, is regulated by Sp/KLF transcription factors.","date":"2003","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/12802284","citation_count":28,"is_preprint":false},{"pmid":"23028046","id":"PMC_23028046","title":"Cellular adaptation to anthrax lethal toxin-induced mitochondrial cholesterol enrichment, hyperpolarization, and reactive oxygen species generation through downregulating MLN64 in macrophages.","date":"2012","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/23028046","citation_count":28,"is_preprint":false},{"pmid":"27205891","id":"PMC_27205891","title":"Relationship between Concentrations of Lutein and StARD3 among Pediatric and Geriatric Human Brain Tissue.","date":"2016","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/27205891","citation_count":27,"is_preprint":false},{"pmid":"22514632","id":"PMC_22514632","title":"MLN64 transport to the late endosome is regulated by binding to 14-3-3 via a non-canonical binding site.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22514632","citation_count":24,"is_preprint":false},{"pmid":"16169523","id":"PMC_16169523","title":"BmStart1, a novel carotenoid-binding protein isoform from Bombyx mori, is orthologous to MLN64, a mammalian cholesterol transporter.","date":"2005","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/16169523","citation_count":22,"is_preprint":false},{"pmid":"34572920","id":"PMC_34572920","title":"STARD3: A Prospective Target for Cancer Therapy.","date":"2021","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/34572920","citation_count":21,"is_preprint":false},{"pmid":"27068960","id":"PMC_27068960","title":"Touché! STARD3 and STARD3NL tether the ER to endosomes.","date":"2016","source":"Biochemical Society transactions","url":"https://pubmed.ncbi.nlm.nih.gov/27068960","citation_count":20,"is_preprint":false},{"pmid":"30996782","id":"PMC_30996782","title":"First-of-its-kind STARD3 Inhibitor: In Silico Identification and Biological Evaluation as Anticancer Agent.","date":"2019","source":"ACS medicinal chemistry letters","url":"https://pubmed.ncbi.nlm.nih.gov/30996782","citation_count":20,"is_preprint":false},{"pmid":"24291029","id":"PMC_24291029","title":"Association analysis of ERBB2 amplicon genetic polymorphisms and STARD3 expression with risk of gastric cancer in the Chinese population.","date":"2013","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/24291029","citation_count":18,"is_preprint":false},{"pmid":"36672312","id":"PMC_36672312","title":"STARD3: A New Biomarker in HER2-Positive Breast Cancer.","date":"2023","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/36672312","citation_count":17,"is_preprint":false},{"pmid":"17589922","id":"PMC_17589922","title":"Overexpression of the cholesterol-binding protein MLN64 induces liver damage in the mouse.","date":"2007","source":"World journal of gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/17589922","citation_count":17,"is_preprint":false},{"pmid":"25459514","id":"PMC_25459514","title":"Mitochondrial proteases act on STARD3 to activate progesterone synthesis in human syncytiotrophoblast.","date":"2014","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/25459514","citation_count":15,"is_preprint":false},{"pmid":"20198306","id":"PMC_20198306","title":"Expression of MLN64 influences cellular matrix adhesion of breast cancer cells, the role for focal adhesion kinase.","date":"2010","source":"International journal of molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/20198306","citation_count":14,"is_preprint":false},{"pmid":"30322615","id":"PMC_30322615","title":"MLN64 deletion suppresses RANKL-induced osteoclastic differentiation and attenuates diabetic osteoporosis in streptozotocin (STZ)-induced mice.","date":"2018","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/30322615","citation_count":12,"is_preprint":false},{"pmid":"38754814","id":"PMC_38754814","title":"Blockade of STARD3-mediated cholesterol transport alleviates diabetes-induced podocyte injury by reducing mitochondrial cholesterol accumulation.","date":"2024","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/38754814","citation_count":11,"is_preprint":false},{"pmid":"36375355","id":"PMC_36375355","title":"Inhibiting the expression of STARD3 induced apoptosis via the inactivation of PI3K/AKT/mTOR pathway on ER+ breast cancer.","date":"2022","source":"Tissue & cell","url":"https://pubmed.ncbi.nlm.nih.gov/36375355","citation_count":8,"is_preprint":false},{"pmid":"29908180","id":"PMC_29908180","title":"Knocking down Stard3 decreases adipogenesis with decreased mitochondrial ROS in 3T3-L1 cells.","date":"2018","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/29908180","citation_count":7,"is_preprint":false},{"pmid":"39370902","id":"PMC_39370902","title":"The lysosomal lipid transporter LIMP-2 is part of lysosome-ER STARD3-VAPB-dependent contact sites.","date":"2024","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/39370902","citation_count":6,"is_preprint":false},{"pmid":"37507014","id":"PMC_37507014","title":"Methionine sulfoxide reductases and cholesterol transporter STARD3 constitute an efficient system for detoxification of cholesterol hydroperoxides.","date":"2023","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/37507014","citation_count":5,"is_preprint":false},{"pmid":"38058811","id":"PMC_38058811","title":"StAR-related lipid transfer domain protein 3 (STARD3) regulates HER2 and promotes HER2-positive breast cancer progression through interaction with HSP90 and SRC signaling.","date":"2023","source":"American journal of cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/38058811","citation_count":5,"is_preprint":false},{"pmid":"33771709","id":"PMC_33771709","title":"Overexpression of STARD3 attenuates oxidized LDL-induced oxidative stress and inflammation in retinal pigment epithelial cells.","date":"2021","source":"Biochimica et biophysica acta. Molecular and cell biology of lipids","url":"https://pubmed.ncbi.nlm.nih.gov/33771709","citation_count":5,"is_preprint":false},{"pmid":"37245582","id":"PMC_37245582","title":"The ultrastructural function of MLN64 in the late endosome-mitochondria membrane contact sites in placental cells.","date":"2023","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/37245582","citation_count":4,"is_preprint":false},{"pmid":"38571685","id":"PMC_38571685","title":"Is STARD3 A New Biomarker for Breast Cancer?","date":"2024","source":"European journal of breast health","url":"https://pubmed.ncbi.nlm.nih.gov/38571685","citation_count":3,"is_preprint":false},{"pmid":"38151289","id":"PMC_38151289","title":"Metastatic Lymph Node 64 (MLN64) Expression in Gastric Cancer: The Clinical and Molecular Implications in Drug Resistance.","date":"2024","source":"Cancer genomics & proteomics","url":"https://pubmed.ncbi.nlm.nih.gov/38151289","citation_count":0,"is_preprint":false},{"pmid":"41741634","id":"PMC_41741634","title":"STARD3 regulates lysosome positioning and contacts via a GSK3-controlled phosphorylation switch.","date":"2026","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/41741634","citation_count":0,"is_preprint":false},{"pmid":"41932487","id":"PMC_41932487","title":"STARD3-like protein from golden noble scallop is a carotenoid transfer protein capable of binding various xanthophylls.","date":"2026","source":"International journal of biological macromolecules","url":"https://pubmed.ncbi.nlm.nih.gov/41932487","citation_count":0,"is_preprint":false},{"pmid":"38835078","id":"PMC_38835078","title":"Detection of novel PPP1R1B::STARD3 fusion transcript in acute myeloid leukemia: a case report.","date":"2024","source":"Journal of medical case reports","url":"https://pubmed.ncbi.nlm.nih.gov/38835078","citation_count":0,"is_preprint":false},{"pmid":"40844562","id":"PMC_40844562","title":"Optimization of Human STARD3 Cholesterol Transporter Expression for Enhancing Bovine P450scc-Mediated Steroid Biotransformation in E. coli.","date":"2025","source":"Molecular biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/40844562","citation_count":0,"is_preprint":false},{"pmid":"42266747","id":"PMC_42266747","title":"Erratum: StAR-related lipid transfer domain protein 3 (STARD3) regulates HER2 and promotes HER2-positive breast cancer progression through interaction with HSP90 and SRC signaling.","date":"2026","source":"American journal of cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/42266747","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.05.29.656564","title":"STARD3 coordinates Endoplasmic Reticulum-late endosome/lysosome contacts and organelle positioning through a GSK3-regulated phosphorylation switch","date":"2025-05-30","source":"bioRxiv","url":"https://doi.org/10.1101/2025.05.29.656564","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.06.09.658757","title":"A network model for patient-derived drug response in breast cancer integrating multi-omics datasets","date":"2025-06-12","source":"bioRxiv","url":"https://doi.org/10.1101/2025.06.09.658757","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":31005,"output_tokens":8171,"usd":0.10779,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":18051,"output_tokens":5449,"usd":0.11324,"stage2_stop_reason":"end_turn"},"total_usd":0.22103,"stage1_batch_id":"msgbatch_013LWZZT6MWaqB9qyTSeQBmU","stage2_batch_id":"msgbatch_0194ZzQaTGNpruoNJBbEMbt3","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1997,\n      \"finding\": \"The C-terminal START/StAR Homology Domain (SHD) of MLN64/STARD3 is necessary and sufficient for steroidogenic activity; deletion of this domain abolishes steroidogenesis, while removal of N-terminal sequences increases it. MLN64 stimulates pregnenolone secretion ~2-fold in COS-1 cells co-transfected with the cholesterol side-chain cleavage enzyme system.\",\n      \"method\": \"COS-1 cell transfection with wild-type and deletion/truncation mutants of MLN64 co-expressed with cholesterol side-chain cleavage enzyme system; pregnenolone secretion assay\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — functional reconstitution assay with systematic mutagenesis/deletion constructs, replicated across multiple construct variants in one rigorous study\",\n      \"pmids\": [\"9237999\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"The N-terminal transmembrane domain of MLN64/STARD3 is responsible for its specific cytoplasmic (perinuclear, bundle-like) localization; deletion of this domain results in uniform cytoplasmic distribution.\",\n      \"method\": \"Deletion mutagenesis with subcellular localization by immunofluorescence microscopy in transfected cells\",\n      \"journal\": \"International journal of cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — deletion mutant with direct localization readout, single lab but two orthogonal observations (IHC and mutagenesis)\",\n      \"pmids\": [\"9139840\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"MLN64/STARD3 localizes exclusively to the limiting membrane of late endosomes via its N-terminal domain, with the START domain projecting into the cytoplasm. A dileucine motif (Leu66-Leu67) and tyrosine residue (Tyr89) in the N-terminal domain are critical for late endosomal targeting or proper folding. MLN64 colocalizes with NPC1 and cholesterol on late endosomes but does not complement NPC2 disease.\",\n      \"method\": \"Immunocytofluorescence, electron microscopy, antibody microinjection/endocytosis, deletion and point mutagenesis of targeting signals, complementation assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (EM, IF, functional complementation, mutagenesis) in one study, rigorous controls\",\n      \"pmids\": [\"11053434\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"The truncated N-218 MLN64 protein (lacking 218 N-terminal residues) has StAR-like steroidogenic activity in vitro, stimulating cholesterol transfer from outer to inner mitochondrial membrane. It adopts a molten-globule-like conformation with pH-dependent structural transitions, and its C-terminus is proteolytically accessible while residues 244–414 are resistant, similar to StAR. MLN64 is proteolytically cleaved in the placenta to a size matching N-218 MLN64.\",\n      \"method\": \"Bacterially expressed N-218 MLN64 tested in isolated mitochondria steroidogenesis assay; CD spectroscopy; limited proteolysis + mass spectrometry; Western blot of human placenta\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — reconstitution in vitro, biophysical characterization (CD), proteolysis mapping, and Western blot validation, multiple orthogonal methods in one study\",\n      \"pmids\": [\"10995240\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Both StAR and N-218 MLN64 act on the outer mitochondrial membrane as molten globules to promote cholesterol transfer; this activity does not require entry into the intramembranous space. Bacterially expressed N-218 MLN64 is active with isolated mitochondria, confirming proper folding.\",\n      \"method\": \"Isolated mitochondria steroidogenesis assay; far-UV CD spectroscopy; urea denaturation; fluorescence spectroscopy; partial proteolysis + mass spectrometry; Western blot\",\n      \"journal\": \"Endocrine research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution and biophysical analysis; single study but multiple orthogonal methods\",\n      \"pmids\": [\"11196440\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"The N-terminal transmembrane domains of MLN64 mediate its endocytosis from the plasma membrane to late endocytic compartments. The START domain transfers free cholesterol from donor to acceptor mitochondrial membranes and enhances steroidogenesis by placental mitochondria. A dominant-negative ΔStart-MLN64 mutant causes free cholesterol accumulation in lysosomes, inhibits late endocytic dynamics, and suppresses steroidogenesis, demonstrating the START domain's role in lysosomal cholesterol mobilization.\",\n      \"method\": \"GFP-tagged MLN64 trafficking analysis; START domain cholesterol transfer assay with isolated mitochondria; ΔStart dominant-negative overexpression; steroidogenesis assay in COS cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (live cell imaging, in vitro transfer assay, dominant-negative genetics, steroidogenesis), replicated in multiple cell types\",\n      \"pmids\": [\"12070139\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"MENTHO, an MLN64 N-terminal domain (MENTAL domain) homologue, interacts with MLN64 via the MENTAL domain; both proteins homo- and hetero-dimerize through this domain. The MENTAL domain targets proteins to late endosomal membranes and binds cholesterol in vivo. MENTHO overexpression alters the endocytic compartment, causing accumulation of enlarged endosomes.\",\n      \"method\": \"cDNA cloning; overexpression and subcellular localization; cholesterol-binding assays; interaction studies; endosome morphology analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — biochemical interaction and localization data plus functional overexpression phenotype; single study\",\n      \"pmids\": [\"12393907\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"N-218 MLN64 stimulates cholesterol transfer between artificial phospholipid vesicles (initial rate 6.5 mol/min·mol) and to the inner mitochondrial membrane of human placental mitochondria (~6-fold stimulation of pregnenolone synthesis), comparable to N-62 StAR. Both proteins undergo pH-dependent molten globule transitions. MLN64 levels in JEG-3 placental cells are unresponsive to cAMP stimulation.\",\n      \"method\": \"In vitro cholesterol transfer assay with phospholipid vesicles; isolated placental mitochondria steroidogenesis assay; urea denaturation; CD spectroscopy; 8-Br-cAMP stimulation of JEG-3 cells\",\n      \"journal\": \"Endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — reconstituted in vitro lipid transfer assay plus mitochondrial function assay, multiple orthogonal methods in one rigorous study\",\n      \"pmids\": [\"14715710\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Targeted mutation of the MLN64 START domain in mice causes only modest alterations in sterol metabolism; mice are viable, fertile, and neurologically intact with no major lipid abnormalities. However, embryonic fibroblasts and granulosa cells from mutant mice show reduced conversion of endogenous cholesterol to steroid hormones, indicating a cell-type-specific role of the START domain in sterol trafficking for steroidogenesis.\",\n      \"method\": \"Targeted mouse gene knockout/mutation; plasma lipid analysis; liver lipid distribution; steroidogenesis assay in primary granulosa cells and transfected embryonic fibroblasts\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo genetic model with multiple cellular and biochemical readouts, multiple orthogonal methods\",\n      \"pmids\": [\"14963026\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Overexpression of full-length MLN64 in hepatocytes blunts StAR-, SCP-2-, and CYP7A1-upregulated bile acid synthesis by ~45–48%, suggesting that full-length MLN64 does not deliver cholesterol to mitochondria or ER for CYP27A1/CYP7A1 and may act as a dominant negative in this context.\",\n      \"method\": \"Adenovirus-mediated overexpression of MLN64, StAR, SCP-2, CYP7A1 in primary rat hepatocytes; bile acid synthesis measurement\",\n      \"journal\": \"Journal of lipid research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional cell-based assay with multiple co-expression conditions; single lab\",\n      \"pmids\": [\"15342684\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"MLN64 depletion causes dispersion of late endocytic organelles to the cell periphery, decreased actin and Arp2/3 (p34-Arc) association with endosomes, impaired fusion of late endocytic organelles, and delayed cargo degradation. MLN64 overexpression increases actin/p34-Arc-positive patches on late endosomes and enhances fusion in an actin-dependent manner. Cholesterol-binding-deficient MLN64 mutants cannot rescue the dispersion phenotype, linking MLN64-mediated sterol transfer to actin-dependent late endosome dynamics.\",\n      \"method\": \"siRNA knockdown; overexpression; live-cell imaging; immunofluorescence for actin and p34-Arc; cargo degradation assay; rescue experiments with cholesterol-binding mutants\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — KD and OE with multiple readouts, mechanistic rescue with point mutants, multiple orthogonal methods in one study\",\n      \"pmids\": [\"15930133\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"The MENTAL domain mediates MLN64 homo- and hetero-interactions with MENTHO, targets both proteins to late endosomal membranes, and binds cholesterol in vivo; the START domain then shuttles cholesterol to cytoplasmic acceptors.\",\n      \"method\": \"Biochemical characterization; cholesterol-binding assays; subcellular fractionation/localization (review/summary of prior experiments)\",\n      \"journal\": \"Biochemical Society transactions\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — review summarizing multiple prior experiments from the same lab; consolidates findings but not new primary data\",\n      \"pmids\": [\"16709157\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"STARD3-START domain and STARD1-START domain differ in their cholesterol-binding modes: cholesterol stabilizes STARD3-START against trypsin degradation (not STARD1-START); photoaffinity labeling with [3H]azocholestanol labels a specific 6.2 kDa fragment in STARD1-START at the hydrophobic cavity wall, whereas label distributes more equally across STARD3-START polypeptides, indicating differential cholesterol-binding mechanisms.\",\n      \"method\": \"Trypsin protection assay; photoaffinity labeling with [3H]azocholestanol; limited proteolysis\",\n      \"journal\": \"The FEBS journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct in vitro biochemical assays comparing the two START domains, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"18331352\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"MLN64 mediates cholesterol transport from late endosomes to mitochondria independently of NPC1. siRNA knockdown of MLN64 in NPC1-deficient CHO cells decreases cholesterol transport to the inner mitochondrial membrane (measured by pregnenolone production) and reduces mitochondrial cholesterol content, establishing MLN64 as required for an NPC1-independent endosome-to-mitochondria cholesterol transport pathway.\",\n      \"method\": \"RNA interference (siRNA) in NPC1-deficient CHO cells stably expressing CYP11A1 complex; pregnenolone production assay; mitochondrial cholesterol content measurement\",\n      \"journal\": \"Journal of lipid research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean RNAi with defined functional readout (steroidogenesis), mitochondrial cholesterol measurement, genetic epistasis with NPC1 loss\",\n      \"pmids\": [\"19965586\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"STARD3/MLN64 selectively binds lutein with high affinity (Kd = 0.45 µM) in the primate retina. Recombinant STARD3 binds lutein (but not zeaxanthin) as assessed by surface plasmon resonance, identifying STARD3 as the macular lutein-binding protein.\",\n      \"method\": \"Surface plasmon resonance (SPR) binding assay with recombinant STARD3; Western blotting; immunohistochemistry in monkey retina\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct binding quantified by SPR with recombinant protein, validated by immunolocalization, single lab\",\n      \"pmids\": [\"21322544\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"MLN64 interacts with 14-3-3 proteins at a non-canonical binding site; blocking this interaction (by 14-3-3 antagonist or MLN64 mutagenesis) delays trafficking of MLN64 to the late endosome and disperses endocytic vesicles to the cell periphery, identifying 14-3-3 as a regulator of MLN64 endosomal trafficking.\",\n      \"method\": \"Affinity chromatography and mass spectrometry to identify interacting partners; co-immunoprecipitation in vitro and in vivo; MLN64 mutagenesis; 14-3-3 antagonist treatment; subcellular localization analysis\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — MS-identified interaction confirmed by Co-IP and functional mutagenesis, single lab\",\n      \"pmids\": [\"22514632\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"LeTx/caspase-1 signaling triggers mitochondrial translocation of MLN64, causing mitochondrial cholesterol enrichment, membrane hyperpolarization, reactive oxygen species generation, and glutathione depletion. Downregulation of MLN64 in toxin-induced-resistant (TIR) cells (mediated by DNMT1-dependent DNA methylation) prevents these mitochondrial events without blocking caspase-1 activation.\",\n      \"method\": \"Subcellular fractionation; cholesterol measurement; mitochondrial membrane potential assay; ROS measurement; siRNA knockdown; DNA methylation analysis; primary macrophage experiments\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional knockdown with multiple organelle-level readouts, single lab, multiple methods\",\n      \"pmids\": [\"23028046\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"MLN64/STARD3 and ORP1L define two distinct subpopulations of late endosomes: MLN64-positive LEs contain ABCA3 and receive endocytosed cargo first, cycling between LE and plasma membrane; ORP1L-positive LEs contain NPC1 and are reached later. MLN64/ABCA3 compartments frequently contact ORP1L/NPC1-containing LEs.\",\n      \"method\": \"Fluorescence microscopy; co-localization analysis; live-cell imaging of endocytic cargo trafficking\",\n      \"journal\": \"Journal of lipid research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — live imaging with defined cargo tracking, single lab, two orthogonal markers\",\n      \"pmids\": [\"23709693\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Mitochondrial metalloproteases cleave STARD3 into a 28-kDa fragment that stimulates progesterone synthesis in isolated human syncytiotrophoblast mitochondria. Metalloprotease inhibitor 1,10-phenanthroline blocks both STARD3 cleavage and steroidogenesis; the 28-kDa fragment stimulates steroidogenesis comparably to truncated STARD3, suggesting proteolytic activation of STARD3 is required for placental cholesterol transport.\",\n      \"method\": \"Isolated syncytiotrophoblast mitochondria; progesterone measurement; Western blot with anti-STARD3; protease inhibitor experiments; 22R-hydroxycholesterol bypass control\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional reconstitution in isolated organelles with inhibitor validation, single lab\",\n      \"pmids\": [\"25459514\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Crystal structure of the lutein-binding domain of human STARD3 refined to 1.74 Å resolution reveals a helix-grip fold around a solvent-filled cavity; rigid-body docking models of lutein indicate one ionone ring must protrude outside the cavity, and steric complementarity involving the ε-ionone ring of lutein may discriminate it from zeaxanthin/meso-zeaxanthin.\",\n      \"method\": \"X-ray crystallography (1.74 Å resolution); rigid-body docking of lutein\",\n      \"journal\": \"Acta crystallographica. Section F, Structural biology communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — crystal structure with docking validation; single lab but direct structural determination\",\n      \"pmids\": [\"27487925\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"STARD3 and its paralogue STARD3NL tether late endosomes to the ER by directly interacting with ER-resident VAP proteins (VAP-A and VAP-B). Both proteins are anchored on late endosomal limiting membranes and the STARD3–VAP interaction scaffolds ER–endosome contact sites affecting endosome dynamics and cholesterol transport.\",\n      \"method\": \"Co-immunoprecipitation; subcellular fractionation; fluorescence co-localization; functional analysis of ER-endosome contacts (review citing own original data)\",\n      \"journal\": \"Biochemical Society transactions\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — review summarizing interaction data; original mechanistic findings from cited primary work (e.g., PMID 28377464)\",\n      \"pmids\": [\"27068960\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"STARD3 mediates ER-to-endosome cholesterol transport at membrane contact sites. STARD3 induces cholesterol accumulation in endosomes at the expense of the plasma membrane. This transport requires both STARD3's lipid transfer (START domain) activity and its ability to form ER-endosome contacts via interaction with VAP (VAMP-associated protein). In vitro reconstitution demonstrated that STARD3 and VAP assemble into a machine enabling highly efficient cholesterol transport within membrane contacts.\",\n      \"method\": \"In situ cholesterol labeling and quantification; in vitro cholesterol transport reconstitution assay; STARD3 mutants deficient in lipid transfer or VAP interaction; cholesterol distribution analysis by filipin staining\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — reconstitution assay, mutagenesis separating two required functions, quantitative in-cell cholesterol measurement, multiple orthogonal methods in one study\",\n      \"pmids\": [\"28377464\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"MLN64 overexpression increases mitochondrial cholesterol content and causes mitochondrial dysfunction including decreased GSH, decreased ATPase activity, decreased mitochondrial membrane potential, mitochondrial fragmentation, and increased mitochondrial superoxide. Reduction of MLN64 expression in NPC1-deficient cells restores mitochondrial membrane potential and reduces superoxide levels, confirming MLN64's role in delivering cholesterol to mitochondria.\",\n      \"method\": \"Adenovirus-mediated MLN64 overexpression in mouse liver and hepatocytes; siRNA knockdown in NPC1-deficient cells; mitochondrial membrane potential (JC-1), ROS, GSH, ATPase assays; electron microscopy\",\n      \"journal\": \"Redox biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — overexpression and knockdown with multiple mitochondrial functional readouts; single lab\",\n      \"pmids\": [\"28282615\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"In NPC1 mutant cells lacking AnxA6, Rab7 activation promotes ER-endosome membrane contact site formation in a STARD3-dependent manner, enabling late endosome-to-ER cholesterol transfer. Electron microscopy confirmed increased LE-ER MCS in AnxA6-deficient NPC1 cells, and genetic depletion of STARD3 was required for Rab7-mediated rescue of cholesterol export.\",\n      \"method\": \"siRNA knockdown of STARD3 and AnxA6; electron microscopy of MCS; cholesterol distribution (filipin); lipid droplet staining; genetic epistasis between AnxA6, TBC1D15/Rab7, and STARD3\",\n      \"journal\": \"Cellular and molecular life sciences : CMLS\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — epistasis with multiple knockdowns and EM validation; single lab, multiple orthogonal methods\",\n      \"pmids\": [\"31664461\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"External cholesterol alters airway epithelial inflammatory sensitivity through a STARD3-MFN2 signaling pathway, causing cholesterol redistribution, altered mitochondrial dynamics, and increased IL production. STARD3 regulation of MFN2 links cholesterol transport to mitochondrial function in bronchial epithelial cells.\",\n      \"method\": \"siRNA knockdown; Western blot; RT-qPCR; mitotracker; Seahorse metabolic assay; lipidomics; electron microscopy\",\n      \"journal\": \"Clinical and translational medicine\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — mechanistic pathway proposed from KD phenotype; single lab, indirect evidence for STARD3-MFN2 interaction\",\n      \"pmids\": [\"35678098\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"STARD3 interacts directly with HSP90 and induces phosphorylated SRC signaling, protecting HER2 from lysosomal degradation. STARD3 overexpression increases HER2 protein levels; STARD3 loss leads to HER2 degradation via lysosomes. STARD3 also promotes cell cycle progression by inducing cyclin D1 and reducing p27.\",\n      \"method\": \"Co-immunoprecipitation (STARD3-HSP90); Western blot for HER2, phospho-SRC, cyclin D1, p27; siRNA knockdown; overexpression; lysosomal inhibitor experiments\",\n      \"journal\": \"American journal of cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — Co-IP plus functional KD/OE with multiple molecular readouts; single lab\",\n      \"pmids\": [\"38058811\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"STARD3 binds all three MSRB isoforms (methionine sulfoxide reductase B) in addition to MSRA; Met307 and Met427 of STARD3 are oxidized by cholesterol-6α-hydroperoxide and cholesterol-7α-hydroperoxide. MSRs reduce these oxidized methionines back to methionine, restoring STARD3 cholesterol-binding activity. This cyclic oxidation-reduction constitutes an efficient mechanism to detoxify cholesterol hydroperoxides during cholesterol transport.\",\n      \"method\": \"Biochemical binding assays; treatment with pure cholesterol hydroperoxide isomers; mass spectrometry of oxidized methionines; MSR-mediated reduction assays; cholesterol-binding activity measurement before/after oxidation\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct in vitro biochemical demonstration of oxidation sites by MS, functional restoration of activity, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"37507014\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"MLN64 is required for the formation of late endosome–mitochondria membrane contact sites in placental cells. Immuno-electron tomography revealed filamentous tethers connecting late endosomes and mitochondria at <20 nm distance; STARD3 knockdown increased this distance to <150 nm and disrupted tether formation. Perturbation of cholesterol egress from endosomes produced an even longer inter-organelle distance.\",\n      \"method\": \"Immuno-electron microscopy; immuno-electron tomography; STARD3 siRNA knockdown; U18666A treatment; distance measurement of contact sites\",\n      \"journal\": \"Experimental cell research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct ultrastructural evidence by electron tomography combined with genetic knockdown and pharmacological perturbation, multiple orthogonal approaches\",\n      \"pmids\": [\"37245582\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"LIMP-2 physically interacts with STARD3 and ER-resident VAPB at ER-lysosome contact sites, and STARD3 is required for the LIMP-2–VAPB interaction. Co-immunoprecipitation and imaging confirmed colocalization and physical interaction, suggesting STARD3 scaffolds a LIMP-2–STARD3–VAPB complex at ER-lysosome MCS to facilitate cholesterol transfer.\",\n      \"method\": \"Proximity-based interaction screen (BioID); co-immunoprecipitation; fluorescence colocalization; STARD3 depletion to test LIMP-2/VAPB interaction dependency\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — proximity screen confirmed by Co-IP and imaging with epistasis test; single lab\",\n      \"pmids\": [\"39370902\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Upregulation of STARD3 under diabetic/hyperglycemic conditions increases cholesterol transport from late endosomes/lysosomes to mitochondria in podocytes, causing mitochondrial cholesterol accumulation and cell injury. Downregulating STARD3 expression attenuates mitochondrial cholesterol accumulation and improves mitochondrial homeostasis.\",\n      \"method\": \"In vivo and in vitro diabetic models; filipin staining for cholesterol subcellular localization; JC-1 for mitochondrial membrane potential; ROS assay; Western blot; siRNA knockdown\",\n      \"journal\": \"Life sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — KD with defined cholesterol redistribution and mitochondrial functional readouts in disease context; single lab\",\n      \"pmids\": [\"38754814\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"GSK3α and GSK3β phosphorylate serine 209 within the Phospho-FFAT motif of STARD3; this phosphorylation is both necessary and sufficient to activate STARD3's tethering activity, promoting ER–late endosome/lysosome contacts. When ER–LE/Lys tethering is prevented (loss of GSK3-mediated phosphorylation), STARD3 triggers LE/Lys homotypic interactions, revealing a second function in endosome biology.\",\n      \"method\": \"Kinase identification by cell-based and biochemical assays; phospho-site mutagenesis (S209); GSK3 inhibition; live-cell imaging of ER-endosome MCS; endosome positioning analysis\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — kinase-site mutagenesis demonstrating necessity and sufficiency, pharmacological GSK3 inhibition, live-cell imaging, and functional endosome phenotype; multiple orthogonal methods\",\n      \"pmids\": [\"41741634\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"STARD3/MLN64 is a late endosomal transmembrane protein whose N-terminal MENTAL domain anchors it to the limiting membrane of late endosomes and mediates homo/heterodimerization, while its cytoplasmic C-terminal START domain binds and transfers cholesterol (one molecule at a time, in a molten-globule-dependent manner) to mitochondria and, at ER–endosome membrane contact sites, to the ER; these contacts are scaffolded by STARD3's Phospho-FFAT motif interacting with ER-resident VAP proteins, a tethering activity switched on by GSK3α/β-mediated phosphorylation of Ser209, and STARD3 additionally regulates actin-dependent late endosome dynamics, forms late endosome–mitochondria contact sites, serves as a retinal lutein-binding protein, and participates in a methionine-oxidation cycle with MSR enzymes to detoxify cholesterol hydroperoxides during transport.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"STARD3 (MLN64) is a late endosomal transmembrane sterol-transfer protein that mobilizes cholesterol from late endosomes/lysosomes to mitochondria and the ER, coupling endosomal lipid handling to steroidogenesis, organelle dynamics, and membrane contact site formation [#5, #13, #21]. Its modular architecture separates targeting from transfer: an N-terminal MENTAL/transmembrane domain anchors the protein to the limiting membrane of late endosomes, mediates homo- and hetero-dimerization (including with MENTHO), and binds cholesterol, while the C-terminal START domain projects into the cytoplasm and shuttles single cholesterol molecules to acceptor membranes [#2, #6, #11]. The START domain is necessary and sufficient for StAR-like steroidogenic activity, stimulating cholesterol transfer to the inner mitochondrial membrane and between phospholipid vesicles as a pH-dependent molten globule, and is proteolytically liberated as an N-218/28-kDa fragment that drives placental steroid synthesis [#0, #3, #7, #18]. This NPC1-independent endosome-to-mitochondria cholesterol route, and the resulting mitochondrial cholesterol loading, governs steroidogenesis but also drives mitochondrial dysfunction—membrane hyperpolarization, ROS, and GSH depletion—when overactive [#13, #22, #16]. STARD3 builds the membrane contact sites underlying this transport: it tethers late endosomes to the ER by binding ER-resident VAP-A/VAP-B through a Phospho-FFAT motif, an interaction switched on by GSK3α/β phosphorylation of Ser209, and reconstitution shows STARD3–VAP assemble an efficient ER-to-endosome cholesterol-transport machine [#20, #21, #30]. STARD3 likewise organizes late endosome–mitochondria contacts and actin/Arp2/3-dependent late endosome dynamics, both dependent on its cholesterol-binding activity [#10, #27]. Beyond cholesterol, STARD3 is the retinal lutein-binding protein, selectively binding lutein over zeaxanthin via its helix-grip START fold [#14, #19], and undergoes a protective methionine-oxidation/MSR-reduction cycle that detoxifies cholesterol hydroperoxides during transport [#26].\",\n  \"teleology\": [\n    {\n      \"year\": 1997,\n      \"claim\": \"Established that STARD3 has a modular two-domain organization, defining the C-terminal START domain as the steroidogenic effector and the N-terminal region as the localization determinant.\",\n      \"evidence\": \"Deletion/truncation mutants co-expressed with cholesterol side-chain cleavage system and localized by immunofluorescence\",\n      \"pmids\": [\"9237999\", \"9139840\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not identify the precise organelle of localization\", \"Mechanism of cholesterol transfer not resolved\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Pinpointed the late endosomal limiting membrane as STARD3's residence and showed the isolated START domain acts as a molten globule transferring cholesterol to mitochondria, resolving how the domains divide labor.\",\n      \"evidence\": \"EM/IF localization with targeting-motif mutagenesis; bacterially expressed N-218 fragment in isolated mitochondria steroidogenesis and CD spectroscopy\",\n      \"pmids\": [\"11053434\", \"10995240\", \"11196440\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not establish physiological cleavage in non-placental tissues\", \"Acceptor specificity beyond mitochondria unaddressed\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Defined the MENTAL domain as the dimerization/cholesterol-binding/endosome-targeting module and showed the START domain mobilizes lysosomal cholesterol, linking sterol transfer to late endocytic function.\",\n      \"evidence\": \"GFP trafficking, in vitro mitochondrial transfer assay, ΔStart dominant-negative overexpression, and MENTHO interaction/cholesterol-binding assays\",\n      \"pmids\": [\"12070139\", \"12393907\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Native heterodimer stoichiometry unknown\", \"How MENTAL-bound cholesterol is handed to START not defined\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Quantified START-domain cholesterol transfer kinetics and tested physiological requirement in vivo, revealing only cell-type-specific steroidogenic dependence rather than global sterol disruption.\",\n      \"evidence\": \"In vitro vesicle/mitochondria transfer assays; targeted START-domain mouse mutant with lipid and steroidogenesis phenotyping; hepatocyte overexpression\",\n      \"pmids\": [\"14715710\", \"14963026\", \"15342684\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Redundancy with other sterol transporters not resolved\", \"Full knockout not characterized in this corpus\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Connected STARD3 sterol transfer to actin-dependent late endosome positioning and fusion, showing the cholesterol-binding function controls organelle dynamics.\",\n      \"evidence\": \"siRNA and overexpression with live imaging, actin/p34-Arc staining, and rescue with cholesterol-binding-deficient mutants\",\n      \"pmids\": [\"15930133\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct link between sterol level and Arp2/3 recruitment not mechanistically defined\", \"Single lab\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Demonstrated that the STARD3 START domain binds cholesterol by a mechanism distinct from STARD1, refining the structural basis of sterol recognition.\",\n      \"evidence\": \"Trypsin protection and photoaffinity labeling comparing STARD3-START and STARD1-START\",\n      \"pmids\": [\"18331352\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"High-resolution cholesterol-bound structure not determined here\", \"Functional consequence of differential binding unclear\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Established STARD3 as required for an NPC1-independent endosome-to-mitochondria cholesterol route, placing it in a parallel pathway to canonical lysosomal cholesterol egress.\",\n      \"evidence\": \"siRNA in NPC1-deficient CHO cells with pregnenolone and mitochondrial cholesterol measurement\",\n      \"pmids\": [\"19965586\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct LE-mitochondria transfer mechanism not visualized here\", \"Contribution relative to NPC1 pathway in vivo unquantified\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Identified STARD3 as the macular lutein-binding protein, extending its ligand repertoire beyond cholesterol.\",\n      \"evidence\": \"Surface plasmon resonance with recombinant STARD3 and retinal immunohistochemistry\",\n      \"pmids\": [\"21322544\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological role of lutein binding in retina not established\", \"Whether lutein and cholesterol binding compete unknown\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Identified regulatory and stress-responsive control of STARD3 trafficking and mitochondrial translocation, showing its localization is actively governed.\",\n      \"evidence\": \"14-3-3 interaction by MS/Co-IP and mutagenesis; LeTx/caspase-1-induced mitochondrial translocation with organelle readouts\",\n      \"pmids\": [\"22514632\", \"23028046\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"14-3-3 binding site not structurally defined\", \"Signaling upstream of mitochondrial translocation incompletely mapped\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Resolved STARD3 into a distinct late endosome subpopulation that contacts NPC1/ORP1L compartments, organizing endosomal cholesterol handling spatially.\",\n      \"evidence\": \"Live-cell imaging and colocalization tracking of MLN64/ABCA3 versus ORP1L/NPC1 endosomes\",\n      \"pmids\": [\"23709693\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular basis of subpopulation segregation unknown\", \"Functional cargo exchange between compartments not measured\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Showed mitochondrial metalloprotease cleavage generates an active STARD3 fragment required for placental steroidogenesis, defining proteolytic activation.\",\n      \"evidence\": \"Isolated syncytiotrophoblast mitochondria, protease inhibitor, and progesterone assays\",\n      \"pmids\": [\"25459514\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Identity of the responsible metalloprotease unresolved\", \"In vivo relevance of cleavage outside placenta unclear\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Determined the helix-grip structure of the START fold and demonstrated direct VAP-dependent ER-endosome tethering, establishing the structural and contact-site machinery.\",\n      \"evidence\": \"1.74 Å crystal structure with lutein docking; Co-IP and colocalization of STARD3/STARD3NL with VAP-A/VAP-B\",\n      \"pmids\": [\"27487925\", \"27068960\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cholesterol-bound structure not solved\", \"FFAT motif and phospho-regulation not yet defined here\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Reconstituted STARD3–VAP as an ER-to-endosome cholesterol-transport machine requiring both lipid transfer and tethering, and linked excess transport to mitochondrial dysfunction.\",\n      \"evidence\": \"In vitro transport reconstitution with function-separating mutants and in-cell filipin cholesterol mapping; overexpression/knockdown mitochondrial functional assays\",\n      \"pmids\": [\"28377464\", \"28282615\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Directionality and regulation of transport in vivo not fully resolved\", \"Coupling between contact formation and transfer rate unquantified\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Placed STARD3-dependent ER-endosome contacts within a Rab7/AnxA6-controlled rescue pathway for cholesterol export in NPC1 disease, integrating it with contact-site regulators.\",\n      \"evidence\": \"siRNA epistasis among STARD3, AnxA6, and TBC1D15/Rab7 with EM of contact sites and filipin\",\n      \"pmids\": [\"31664461\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism by which Rab7 activation promotes STARD3 contacts unclear\", \"Therapeutic relevance untested\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Expanded STARD3's interactome and protective biochemistry, defining LE-mitochondria contacts, a methionine-oxidation/MSR detox cycle, and an HSP90/HER2 stabilizing role.\",\n      \"evidence\": \"Immuno-electron tomography with STARD3 knockdown; MS mapping of oxidized Met307/Met427 with MSR reduction assays; Co-IP and KD/OE of HER2/phospho-SRC pathway\",\n      \"pmids\": [\"37245582\", \"37507014\", \"38058811\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How LE-mitochondria tethers form molecularly not fully defined\", \"STARD3-HSP90-HER2 mechanism is single-lab and indirect\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Extended STARD3's contact-site scaffolding and disease relevance, showing it bridges LIMP-2–VAPB at ER-lysosome contacts and drives mitochondrial cholesterol injury in diabetic podocytes.\",\n      \"evidence\": \"BioID/Co-IP with STARD3-depletion epistasis; diabetic in vivo/in vitro models with filipin and mitochondrial readouts\",\n      \"pmids\": [\"39370902\", \"38754814\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Stoichiometry of LIMP-2–STARD3–VAPB complex unknown\", \"Causality in disease versus correlation not fully separated\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Identified GSK3α/β phosphorylation of Ser209 as the switch activating STARD3 tethering, and uncovered a second STARD3 function promoting homotypic endosome interactions when tethering is off.\",\n      \"evidence\": \"Kinase identification, S209 phospho-mutagenesis, GSK3 inhibition, and live-cell imaging of ER-endosome contacts and endosome positioning\",\n      \"pmids\": [\"41741634\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Upstream signals controlling GSK3 toward STARD3 unknown\", \"Physiological trigger toggling between tethering and homotypic function undefined\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How STARD3's multiple roles—cholesterol transfer, lutein binding, contact-site tethering, and oxidative detoxification—are coordinated and prioritized within a single cell remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No integrated model of how ligand selection (cholesterol vs lutein) is regulated\", \"Tissue-specific functional hierarchy not established\", \"In vivo loss-of-function consequences beyond conditional models incompletely defined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0008289\", \"supporting_discovery_ids\": [3, 5, 6, 7, 14, 21, 26]},\n      {\"term_id\": \"GO:0140104\", \"supporting_discovery_ids\": [5, 13, 21]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [20, 21, 28]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [2, 5, 6, 17]},\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [20, 21, 28]},\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [13, 16, 22, 27]},\n      {\"term_id\": \"GO:0005764\", \"supporting_discovery_ids\": [5, 28]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [0, 5, 13, 21]},\n      {\"term_id\": \"R-HSA-5653656\", \"supporting_discovery_ids\": [20, 21, 27]}\n    ],\n    \"complexes\": [\n      \"STARD3-VAP ER-endosome contact tether\",\n      \"LIMP-2-STARD3-VAPB ER-lysosome contact complex\",\n      \"MLN64-MENTHO heterodimer\"\n    ],\n    \"partners\": [\n      \"VAPA\",\n      \"VAPB\",\n      \"STARD3NL\",\n      \"MENTHO\",\n      \"HSP90\",\n      \"LIMP-2\",\n      \"MFN2\",\n      \"MSRA\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}